Texas physician pleads guilty in $5.5M COVID fraud

Mark Mazzare, MD, a physician in Tyler, Texas, has pleaded guilty to his role in a $5.5 million over-the-counter COVID-19 test fraud scheme. 

Advertisement

According to a Dec. 16 news release from the Justice Department, Dr. Mazzare purchased Medicare beneficiary ID numbers and used them to bill Medicare for millions of dollars in OTC COVID-19 test kits, many of which were not requested by beneficiaries. 

Dr. Mazzare partnered with a “purported marketer” to conceal the identification numbers as “lead packages,” which were actually fraudulently created audio recordings purported to be the voices of the beneficiaries requesting the test kits. He then caused the test to be shipped to the beneficiaries tied to each ID number, regardless of whether they had actually ordered the tests. 

This resulted in more than $5.5 million in medically unnecessary and ineligible claims for COVID-19 tests to be submitted to Medicare between November 2022 and June 2023. Medicare paid approximately $3.44 million of these claims. 

Dr. Mazzare pleaded guilty to conspiracy to defraud the government and to purchasing, selling and distributing Medicare beneficiary ID numbers. He faces a maximum penalty of five years in prison.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.